Statin treatment patterns and clinical profile of patients with risk factors for coronary heart disease defined by National Cholesterol Education Program Adult Treatment Panel III

被引:12
|
作者
Kern, David M. [1 ]
Balu, Sanjeev [2 ]
Tunceli, Ozgur [1 ]
Anzalone, Deborah [2 ]
机构
[1] HealthCore Inc, Wilmington, DE 19801 USA
[2] AstraZeneca Pharmaceut LP, Wilmington, DE USA
关键词
Adherence; Coronary heart disease; Dyslipidemia; Retrospective; Statins; MEDICATIONS; GUIDELINES; UPDATE;
D O I
10.1185/03007995.2014.971151
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To compare clinical characteristics, statin treatment patterns and adherence among patients at different risk for coronary heart disease (CHD) as defined by National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III guidelines. Methods: Patients >= 18 years old with >= 1 claim for dyslipidemia, >= 1 statin claim, or >= 1 LDL-C value >= 100 mg/dL were identified from 1 January 2007 to 31 July 2012. Patients were classified as low risk (LR) (0-1 risk factor: hypertension, age >= 45 years [men] or >= 55 years [women], or low HDL-C), moderate/moderately high risk (MR) (>= 2 risk factors), high risk (HR) (CHD or CHD risk equivalent), or very high risk (VHR) (acute coronary syndrome, or established cardiovascular disease plus diabetes or metabolic syndrome). Medication use and lipid levels during the 12 months before and statin use during the 6 months after index were compared across risk groups. Results: There were 1,524,351 LR, 242,357 MR, 188,222 HR, and 57,469 VHR patients identified. Statin use was observed in 15% of all patients, but was higher in the VHR group (45%) versus LR (12%), MR (18%), and HR (29%) groups. Simvastatin accounted for 50%-52% of all statin use, and average statin dose was higher among VHR patients compared with all other groups. Adherence was low overall (mean proportion of days covered [PDC]: 0.57), but higher among VHR (0.69) versus others (mean PDC: 0.55, 0.59, and 0.59 in LR, MR, and HR groups, respectively). Conclusions: Statin treatment was low across all risk groups, and VHR patients had higher doses and better adherence compared with other risk groups. However, adherence was not optimal, indicating a potential limited benefit from statin treatment.
引用
收藏
页码:2443 / 2451
页数:9
相关论文
共 50 条
  • [41] Testing national cholesterol education program-adult treatment panel III (NCEP-ATP III) guidelines for central obesity in African Americans
    Sen, Salbyasachi
    Chow, Carson C.
    Ricks, Madia
    Sebring, Nancy G.
    Frempong, Barbara A.
    Sumner, Anne E.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E113 - E114
  • [42] Metabolic syndrome and cardiac disease in Japanese men: Applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment panel III to Japanese men - The Tanno and Sobetsu study
    Takeuchi, H
    Saitoh, S
    Takagi, S
    Ohnishi, H
    Ohhata, J
    Isobe, T
    Shimamoto, K
    HYPERTENSION RESEARCH, 2005, 28 (03) : 203 - 208
  • [43] Statin therapy is critical in heart failure patients who meet national cholesterol education panel high risk criteria
    Krasuski, RA
    Smith, B
    Stajduhar, KC
    Kwan, MD
    Ellis, R
    Galbreath, AD
    Freeman, GL
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 390A - 390A
  • [44] MISMATCH OF CORONARY RISK AND TREATMENT INTENSITY UNDER THE NATIONAL CHOLESTEROL EDUCATION-PROGRAM GUIDELINES
    MCISAAC, WJ
    NAYLOR, CD
    BASINSKI, A
    JOURNAL OF GENERAL INTERNAL MEDICINE, 1991, 6 (06) : 518 - 523
  • [45] Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals
    Feldman, T
    Koren, M
    Insull, M
    McKenney, J
    Schrott, H
    Lewin, A
    Shah, S
    Sidisin, M
    Cho, MY
    Kush, D
    Mitchel, Y
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (12): : 1481 - 1486
  • [46] Waiting for the National Cholesterol Education Program Adult Treatment Panel IV Guidelines, and in the Meantime, Some Challenges and Recommendations
    Martin, Seth S.
    Metkus, Thomas S.
    Horne, Aaron
    Blaha, Michael J.
    Hasan, Rani
    Campbell, Catherine Y.
    Yousuf, Omair
    Joshi, Parag
    Kaul, Sanjay
    Miller, Michael
    Michos, Erin D.
    Jones, Steven R.
    Gluckman, Ty J.
    Cannon, Christopher P.
    Sperling, Laurence S.
    Blumenthal, Roger S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (02): : 307 - 313
  • [47] Cholesterol treatment levels in high risk patients for coronary heart disease.
    Ball, B
    Hopkins, PN
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (01) : 90A - 90A
  • [48] Can we apply the national cholesterol education program adult treatment panel definition of the metabolic syndrome to Asians?
    Tan, CE
    Ma, S
    Wai, D
    Chew, SK
    Tai, ES
    DIABETES CARE, 2004, 27 (05) : 1182 - 1186
  • [49] Prevalence of Metabolic Syndrome among Korean Adolescents According to the National Cholesterol Education Program, Adult Treatment Panel III and International Diabetes Federation
    Kim, Seonho
    So, Wi-Young
    NUTRIENTS, 2016, 8 (10)
  • [50] Higher prevalence of metabolic syndrome by the international diabetes federation (IDF) than the adult treatment panel III national cholesterol education program criteria
    Nawawi, H.
    Ismail, T.
    Mansor, N. M.
    Mahyuddin, M. M.
    Razali, R.
    Muid, S.
    Azlina, A. R.
    Yusoff, K.
    JOURNAL OF HYPERTENSION, 2006, 24 : S207 - S207